Recently, genetic counselling and genetic testing of BRCA1 and BRCA2 for the presence of germline inactivating mutations have been increasingly offered to identify individuals at elevated risk of breast and ovarian cancer in Korea. This evidence concerns the gene BRCA1 and ovarian cancer.